M Sterneck
Overview
Explore the profile of M Sterneck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
von der Schulenburg P, Herting A, Harberts A, Lutgehetmann M, Jahnke-Triankowski J, Pischke S, et al.
United European Gastroenterol J
. 2024 Jan;
12(3):339-351.
PMID: 38279837
Background: In the third year of the SARS-CoV-2 pandemic, little is known about the vaccine- and infection-induced immune response in liver transplant recipients (LTR) and liver cirrhosis patients (LCP). Objective:...
2.
Roeb E, Canbay A, Bantel H, Bojunga J, de Laffolie J, Demir M, et al.
Z Gastroenterol
. 2022 Sep;
60(9):1346-1421.
PMID: 36100202
No abstract available.
3.
Huebener P, Sterneck M, Fuhrmann V
Aliment Pharmacol Ther
. 2018 Jun;
48(1):100-101.
PMID: 29882978
No abstract available.
4.
Horvatits T, Pischke S, Proske V, Fischer L, Scheidat S, Thaiss F, et al.
United European Gastroenterol J
. 2018 Feb;
6(1):104-111.
PMID: 29435320
Background: Since introduction of the MELD score in the liver allograft allocation system, renal insufficiency has emerged as an increasing problem. Here we evaluated the course of kidney function in...
5.
Thude H, Rother S, Sterneck M, Klempnauer J, Nashan B, Schwinzer R, et al.
HLA
. 2017 Nov;
91(1):52-55.
PMID: 29111570
The killer cell lectin-like receptor B1 (KLRB1) gene encodes for CD161 expressed by different subsets of leukocytes involved in the development of acute liver transplant rejection. The single nucleotide polymorphism...
6.
Zimmermann T, Beckebaum S, Berg C, Berg T, Braun F, Eurich D, et al.
Z Gastroenterol
. 2016 Jul;
54(7):665-84.
PMID: 27429106
With the approval of new direct acting antiviral agents (DAA), therapeutic options for patients with chronic hepatitis C virus (HCV) infection are now generally available before and after liver transplantation...
7.
Ciesek S, Proske V, Otto B, Pischke S, Costa R, Luthgehetmann M, et al.
Transpl Infect Dis
. 2016 Mar;
18(3):326-32.
PMID: 26988272
Background: Hepatitis C virus (HCV) infection is associated with a particularly poor outcome after liver transplantation. In December 2014, sofosbuvir/ledipasvir (SOF/LDV) fixed-dose combination (FDC) was approved for HCV genotype 1...
8.
Pischke S, Polywka S, Proske V, Lang M, Jordan S, Nashan B, et al.
Transpl Infect Dis
. 2015 Oct;
18(1):141-5.
PMID: 26485543
Background: Hepatitis C virus (HCV) infection is associated with reduced graft survival in orthotopic liver transplant recipients. Treatment with the new direct-acting antivirals (DAAs) is safe and efficient, but no...
9.
Meisner S, Polywka S, Memmler M, Nashan B, Lohse A, Sterneck M, et al.
Am J Transplant
. 2015 Aug;
15(11):3011-2.
PMID: 26288311
No abstract available.
10.
Hartl J, Kreuels B, Polywka S, Addo M, Luethgehetmann M, Dandri M, et al.
Z Gastroenterol
. 2015 Jul;
53(7):639-43.
PMID: 26167693
Background: Hepatitis A and hepatitis E are not limited to tropical countries but are also present in industrialized countries. Both infections share similar clinical features. There is no comparative study...